Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0LWKPR
ADC Name
ch28-MalPeg6C2-8261
Synonyms
ch28 MalPeg6C2-8261
   Click to Show/Hide
Organization
Pfizer Inc.
Drug Status
Investigative
Indication
In total 4 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Non small cell lung cancer [ICD11:2C25]
Investigative
Osteosarcoma [ICD11:2B51]
Investigative
Ovarian cancer [ICD11:2C73]
Investigative
Drug-to-Antibody Ratio
4.3
Antibody Name
Anti-NOTCH3 mAb ch28
  Antibody Info 
Antigen Name
Neurogenic locus notch homolog protein 3 (NOTCH3)
  Antigen Info 
Payload Name
Undisclosed
Linker Name
ch28-MalPeg6C2-8261 linker
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal Inhibitory Concentration (IC50) 
83
ng/mL
CVCL_0419
Breast adenocarcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50) 83.00 ng/mL Positive NOTCH3 expression (NOTCH3+++/++)
Method Description
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.

   Click to Show/Hide
In Vitro Model Breast adenocarcinoma MDA-MB-468 cells CVCL_0419
References
Ref 1 Anti-notch3 antibodies and antibody-drug conjugates.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.